Landscapes / Targets
estrogen receptor
16 drugs act on estrogen receptor, in 75 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs16
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Estrogen receptor antagonist |
Approved | Nov 2026soonPhase 2 trial completes | |||
| How it works | Blocks oestrogen from acting on cells | ||||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Breast Cancer, Metastatic Breast Cancer and 9 more | ||||
| Open drug page | |||||
— |
Rigel Pharmaceuticals +2 · Public PFE |
Approved | 30 Dec 2026Phase 3 trial completes | ||
| Next date | 30 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer, Locally Advanced or Metastatic ER+ HER2- Breast Cancer and 3 more | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Approved | 20 Apr 2027Phase 3 trial completes | ||
| Next date | 20 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | ER-Positive HER2-Negative Breast Cancer, ER+ HER2- Advanced Breast Cancer and 17 more | ||||
| Open drug page | |||||
Estrogen receptor antagonist |
Eli Lilly · Public LLY |
Approved | Oct 2027Phase 3 trial completes | ||
| How it works | Blocks oestrogen from acting on cells | ||||
| Next date | Oct 2027 · Phase 3 trial completes | ||||
| Also tested for | Breast Neoplasms, Breast Cancer and 5 more | ||||
| Open drug page | |||||
Estrogen receptor antagonist |
AstraZeneca · Public AZN |
Approved | 1 Nov 2027Phase 3 trial completes | ||
| How it works | Blocks oestrogen from acting on cells | ||||
| Next date | 1 Nov 2027 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer, Locally Advanced (Inoperable) or Metastatic Breast Cancer and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Nov 2026soonPhase 3 trial completes | |||
| Next date | 30 Nov 2026 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 3 | Apr 2027Phase 3 trial completes | |||
| Next date | Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Metastatic Breast Cancer | ||||
| Open drug page | |||||
— |
Roche · Public ROG.SW |
Phase 3 | 31 Jul 2027Phase 2 trial completes | ||
| Next date | 31 Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Early Breast Cancer, Breast Cancer and 12 more | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Aug 2028Phase 3 trial completes | |||
| Next date | 31 Aug 2028 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer, Locally Advanced or Metastatic Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2028Phase 3 trial completes | |||
| Next date | Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer, Metastatic Breast Cancer and 11 more | ||||
| Open drug page | |||||
— |
Phase 2 | Nov 2026soonPhase 2 trial completes | |||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Breast Neoplasms, Invasive Breast Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Dec 2026Phase 2 trial completes | |||
| Next date | 31 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Vulvo Vaginal Atrophy (VVA) | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Oct 2027Phase 2 trial completes | |||
| Next date | 31 Oct 2027 · Phase 2 trial completes | ||||
| Also tested for | Breast Cancer, Ovarian Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Metastatic Castration-resistant Prostate Cancer (mCRPC) | ||||
| Open drug page | |||||
— |
Phase 1 | Nov 2026soonPhase 1 trial completes | |||
| Next date | Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced or Metastatic Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Breast Cancer | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 16 of 16 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026